S
Stockadora

Recent Material Events

Track the latest material events (8-K filings) with AI-powered analysis. Stay informed about major corporate developments, acquisitions, and changes.

📊 1045 Events
🤖 AI Analyzed
Recent
📄 Page 46 of 88
dMY Squared Technology Group, Inc.
8-K March 17, 2026

Key Highlights

  • dMY Squared Technology Group, Inc. (DMYS) is transforming from a SPAC into a pub...
  • Shareholders approved the merger with Horizon Quantum Computing Pte. Ltd. on Mar...
  • The combined entity will be named Horizon Quantum Holdings Ltd. and is expected ...
Read Analysis
🤖 AI Generated
Bunge Global SA
8-K March 17, 2026

Key Highlights

  • Bunge completed a transformative $8.2 billion acquisition of Viterra, solidifyin...
  • The acquisition aims to expand Bunge's global footprint, diversify product offer...
  • Bunge anticipates realizing approximately $250 million in annual run-rate synerg...
Read Analysis
🤖 AI Generated
Black Hawk Acquisition Corp
8-K March 17, 2026

Key Highlights

  • Dr. Michael Tolentino appointed CEO of Vesicor Therapeutics, effective March 17,...
  • Former CEO Luo Feng transitions to Chief Scientific Officer (CSO), allowing focu...
  • Dr. Tolentino brings over two decades of experience in drug discovery, developme...
Read Analysis
🤖 AI Generated
VisionWave Holdings, Inc.
8-K March 17, 2026

Key Highlights

  • VisionWave Holdings, Inc. increased its ownership in SaverOne Ltd. to roughly 21...
  • The move aims to leverage SaverOne's innovative ADAS technology to enhance Visio...
  • Expected to create synergies through technology integration, market expansion, a...
Read Analysis
🤖 AI Generated
FIRST REAL ESTATE INVESTMENT TRUST OF NEW JERSEY, INC.
8-K March 17, 2026

Key Highlights

  • Strong residential portfolio performance driving earnings and dividend growth th...
  • Significant increase in Earnings Per Share (EPS) to $0.13 (from $0.08) and Adjus...
  • Quarterly dividend increased to $0.10 per share, signaling management confidence...
Read Analysis
🤖 AI Generated
JACOBS SOLUTIONS INC.
8-K March 17, 2026

Key Highlights

  • Jacobs is sharpening its focus on high-growth, higher-margin Critical Human Infr...
  • The full acquisition of PA Consulting significantly enhances Jacobs' digital, in...
  • The spin-off creates a new, independent, publicly traded government services com...
Read Analysis
🤖 AI Generated
APTARGROUP, INC.
8-K March 17, 2026

Key Highlights

  • Internal promotion of Gael Touya ensures continuity and leverages deep instituti...
  • The transition is designed to sustain strategic momentum, particularly within th...
  • An orderly and planned succession, supported by former CEO Stephan Tanda's advis...
Read Analysis
🤖 AI Generated
WATERS CORP /DE/
8-K March 16, 2026

Key Highlights

  • Strategic entry into the high-growth clinical diagnostics and infectious disease...
  • Acquired business adds approximately $400 million in annual revenue.
  • Expected to be accretive to Waters' non-GAAP earnings per share by 5-7% in the f...
Read Analysis
🤖 AI Generated
AIR INDUSTRIES GROUP
8-K March 16, 2026

Key Highlights

  • AIR INDUSTRIES GROUP (AIRI) is a key manufacturer of critical components for the...
  • CEO resignation was not due to any disagreement, suggesting an amicable departur...
  • No immediate material financial impacts or extraordinary severance packages were...
Read Analysis
🤖 AI Generated
CERUS CORP
8-K March 16, 2026

Key Highlights

  • Planned succession: Vivek Jayaraman promoted to President and CEO, with outgoing...
  • New CEO brings extensive experience (COO since 2020, CCO since 2016) to accelera...
  • Substantial compensation package for Mr. Jayaraman ($740K base, 80% bonus target...
Read Analysis
🤖 AI Generated
RADNOSTIX INC
8-K March 16, 2026

Key Highlights

  • DUF6 Plant sale terminated, but RADNOSTIX now believes the asset is significantl...
  • Potential for higher long-term shareholder value from the re-evaluated DUF6 Plan...
  • Core Generic Sodium Iodide I-131 product remains unaffected by the capsule recal...
Read Analysis
🤖 AI Generated
BIOMARIN PHARMACEUTICAL INC
8-K March 16, 2026

Key Highlights

  • VOXZOGO is already a successful and revenue-generating drug for achondroplasia, ...
  • Trials for VOXZOGO in children with Noonan syndrome and most cases of idiopathic...
  • BioMarin demonstrates a strong commitment to patient safety by pausing trials ou...
Read Analysis
🤖 AI Generated

Stay Informed with AI Analysis

Get comprehensive insights from material event filings with our AI-powered analysis. Track corporate developments, acquisitions, and strategic changes.

Back to Homepage